Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate DexCom, Inc. before investing.

In this article, we go over a few key elements for understanding DexCom, Inc.’s stock price such as:

• DexCom, Inc.’s current stock price and volume
• Why DexCom, Inc.’s stock price changed recently
• Upgrades and downgrades for DXCM from analysts
• DXCM’s stock price momentum as measured by its relative strength

About DexCom, Inc. (DXCM)

Before we jump into DexCom, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Want to learn more about DexCom, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about DexCom, Inc..

DexCom, Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, DexCom, Inc.’s stock price was $83.450.

DexCom, Inc. is up 11.95% from its previous closing price of $74.540.

During the last market session, DexCom, Inc.’s stock traded between $79.500 and $84.700. Currently, there are approximately 382.20 million shares outstanding for DexCom, Inc..

DexCom, Inc.’s price-earnings (P/E) ratio is currently at 32.9, which is high compared to the Health Care Equipment & Supplies industry median of 31.1. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

DexCom, Inc. Stock Price History

DexCom, Inc.’s (DXCM) price is currently up 23.91% so far this month.

During the month of July, DexCom, Inc.’s stock price has reached a high of $84.700 and a low of $67.870.

Over the last year, DexCom, Inc. has hit prices as high as $84.700 and as low as $54.110. Year to date, DexCom, Inc.’s stock is up 25.73%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused DexCom, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there was 1 analyst who downgraded DexCom, Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate DexCom, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on DexCom, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

DexCom, Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about DexCom, Inc. (DXCM) by visiting AAII Stock Evaluator.

Relative Price Strength of DexCom, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, DexCom, Inc. has a weighted four-quarter relative price strength of 5.44%, which translates to a Momentum Score of 72 and is considered to be Strong.

Want to learn more about how DexCom, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

DexCom, Inc. Stock Price: Bottom Line

As of July 31, 2026, DexCom, Inc.’s stock price is $83.450, which is up 11.95% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like DexCom, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.